Knowledge

The Sinopharm Vaccine’s Mechanism of Action

Beijing Institute of Biological Products developed BBIBP-CorV, an inactivated coronavirus vaccine, in early 2020. Clinical experiments conducted by the state-owned corporation Sinopharm demonstrated a 79%